Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lee, PA
Andrew Max Lee, Oreland, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100131016 | LESS INVASIVE SURGICAL SYSTEM AND METHODS - A system for performing a less invasive surgical procedure and, in particular, devices and methods for spinal fixation. The system comprises dilation tool(s), at least one working/insertion cannula, a plurality of screws, at least one fixation rod for connecting the screws, and a rod inserter. The dilation tool(s) may be used to dilate an incision made in a patient to form an opening. Thereafter, a drill may be used to form holes in the vertebrae. An insertion cannula may be attached to a screw and inserted into the opening. The screws may be polyaxial screws and may be inserted into the vertebrae using a screwdriver. An operator may then move the insertion cannula to manipulate a head portions of the screws such that the head portions may be aligned to receive a fixation rod. A rod inserter may be used to insert a fixation rod into the head portions. After the fixation rod is in place, it may be locked to the screws, thereby fixing the system in place on the spine. | 05-27-2010 |
Bin Lee, Coraopolis, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080227879 | Water-blown polyurethane foams and a process for their production - Water-blown polyurethane foams are made by reacting a polyisocyanate with a polyol component which includes at least one polyether polyol in the presence of water and a modified, non-fugitive amine catalyst. | 09-18-2008 |
Byounghee Lee, Wexford, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100046060 | TUNABLE PLASMONIC FILTER - A tunable plasmonic filter or an optical filtering method discloses plasmonic filter structure and a voltage or current source. An intensity or wavelength of light transmitted through the filter structure is modulated by the intensity of a voltage or current from the voltage or current source. The plasmonic filter structure is located between electrodes electrically connected to the voltage or current source. The plasmonic filter structure is configured such that the incident light is resonant with at least one plasmonic mode on the structure, and a predetermined wavelength will perturb the metallic plasmonic structure in surface plasmon on energy bands for the wavelength selective transmission of light. | 02-25-2010 |
| 20100046077 | WAVELENGTH SELECTIVE METALLIC EMBOSSING NANOSTRUCTURE - In accordance with embodiments of the present invention, a nano structure optical wavelength filter is provided. A film made of a negative dielectric constant material such as a metal has embossing structures of subwavelength scale, located thereon in an array in a pattern. The array pattern and the structures are configured such that when light is incident on the array structures, at least one plasmon mode is resonant with the incident light to produce a transmission spectral window with desired spectral profile, bandwidth and beam shape. | 02-25-2010 |
| 20100053755 | PLASMONIC FABRY-PEROT FILTER - A plasmonic Fabry-Perot filter includes a first partial mirror and a second partial mirror separated from the first partial mirror by a gap. At least one of the first partial mirror or the second partial mirror includes an integrated plasmonic optical filter array. | 03-04-2010 |
| 20100182598 | DIGITAL FILTER SPECTRUM SENSOR - A spectrum sensing method includes (a) receiving an incident radiation simultaneously through a filter array composed of multiple bandpass filters, (b) digitizing spectral responses of the filter array, and (c) generating an estimate of spectral profile of the incident radiation based on digitized spectral responses of the filter array. | 07-22-2010 |
Byounghee Lee, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110086676 | MULTI-PURPOSE PLASMONIC AMBIENT LIGHT SENSOR AND VISUAL RANGE PROXIMITY SENSOR - A visible wavelength range proximity sensor includes a visible light emitter with a peak wavelength in a visible wavelength range, and a plasmonic ambient light sensor, where a proximity sensing mode and an ambient light sensing mode are time multiplexed. | 04-14-2011 |
| 20120129269 | NANO-OPTIC FILTER ARRAY BASED SENSOR - A device such as a filter or reflector includes a conductive layer including a periodic pattern of elements. The elements have shapes and sizes configured such that a transmittance or reflectance spectrum of the conductive layer has a drop at a long-wavelength end. The elements have a period configured such that the spectrum has a dip at a Plasmon mode resonant wavelength. The spectrum further includes a peal- between the dip and the drop. | 05-24-2012 |
Byung-Yong Lee, Jenkintown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110159109 | TITANIA DISPERSION AND METHOD FOR MAKING - A novel method for preparing a titania dispersion by blending two different titania dispersions synthesized by a solvothermal process and a hydrolysis process. The titania dispersion has a plurality of titania particles substantially uniformly dispersed therein and can be blended to provide a high concentration of titania with an anatase crystalline structure to provide the desired level of photocatalytic activity. The present invention also permits the preparation of transparent titania dispersions. The solution may be used for various decontamination and clean energy generation applications. | 06-30-2011 |
| 20110192789 | METAL OR METAL OXIDE DEPOSITED FIBROUS MATERIALS - A method for electrospraying nanosized metal or metal oxide particles onto a substrate. A metal oxide deposited fibrous material comprising a substrate, fibers and metal oxide particles may be made using the method. The material may be a flexible and porous fibrous matrix on which metal oxide particles may be uniformly deposited on a surface thereof. In an exemplary embodiment, the invention is directed to an electrospun nanofibrous material on which electrosprayed photocatalytic metal oxide particles are uniformly deposited without agglomeration. | 08-11-2011 |
Chao-Pin Lee, King Of Prussia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080306045 | 1-Benzazepine-3-Sulfonylamino-2-Pyrroridones as Factor Xa Inhibitors - The invention relates to chemical entities of formula (I): | 12-11-2008 |
Christopher Lee, Lansdowne, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110078174 | SYSTEMS AND METHODS FOR SCHEDULING RECORDINGS USING CROSS-PLATFORM DATA SOURCES - Systems and methods are provided for scheduling media asset actions (e.g., media asset reminders, media asset recordings, etc.) on media assets, based on a user's list of favored artists (e.g., actor/actress, band, celebrity, etc.). A system that obtains a list of artists that are favored by a user is provided. Information is obtained from a website, where the obtained information indicates that one of the artists in the list is scheduled to perform during a particular time. Based on the obtained information, a media asset action is scheduled for the identified media asset. | 03-31-2011 |
Christopher Watson Lee, Lansdowne, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110078717 | SYSTEM FOR NOTIFYING A COMMUNITY OF INTERESTED USERS ABOUT PROGRAMS OR SEGMENTS - Methods and systems that allow a user to notify other users in a community group about the availability of program segments in which the other users may have an interest are provided. In some embodiments, a user selection of a program segment of interest may be received using user equipment. A network may be searched for the location of the program segment, using the user equipment. A reference associated with the location of the program segment on the network may be created. The reference may be shared with a community of interested users, using the user equipment. The community of interested users may be notified about the program segment using the reference. | 03-31-2011 |
Daeyeon Lee, Wynnewood, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120136180 | Imprinted Biomimetic Catalysts for Cellulose Hydrolysis - The present disclosure describes methods and biomimetic catalysts useful for hydrolyzing glucose polymers, such as cellulose, and oligomers, such as cellobiose, to glucose for the subsequent production of ethanol. | 05-31-2012 |
Daeyeon Lee, Wynewood, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110305761 | POLYMERSOMES, COLLOIDOSOMES, LIPOSOMES, AND OTHER SPECIES ASSOCIATED WITH FLUIDIC DROPLETS - The present invention relates generally to vesicles such as liposomes, colloidosomes, and polymersomes, as well as techniques for making and using such vesicles. In some cases, the vesicles may be at least partially biocompatible and/or biodegradable. The vesicles may be formed, according to one aspect, by forming a multiple emulsion comprising a first droplet surrounded by a second droplet, which in turn is surrounded by a third fluid, where the second droplet comprises lipids and/or polymers, and removing fluid from the second droplet, e.g., through evaporation or diffusion, until a vesicle is formed. In certain aspects, the size of the vesicle may be controlled, e.g., through osmolarity, and in certain embodiments, the vesicle may be ruptured through a change in osmolarity. In some cases, the vesicle may contain other species, such as fluorescent molecules, microparticles, pharmaceutical agents, etc., which may be released upon rupture. Yet other aspects of the invention are generally directed to methods of making such vesicles, kits involving such vesicles, or the like. | 12-15-2011 |
David Changsoo Lee, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110235908 | PARTITION MIN-HASH FOR PARTIAL-DUPLICATE IMAGE DETERMINATION - Images in a database or collection of images are each divided into multiple partitions with each partition corresponding to an area of an image. The partitions in an image may overlap with each other. Min-hash sketches are generated for each of the partitions and stored with the images. A user may submit an image and request that an image that is a partial match for the submitted image be located in the image collection. The submitted image is similarly divided into partitions and min-hash sketches are generated from the partitions. The min-hash sketches are compared with the stored min-hash sketches for matches, and images having partitions whose sketches are matches are returned as partial matching images. | 09-29-2011 |
David Edward Lee, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120137254 | CONTEXT-AWARE AUGMENTED COMMUNICATION - Systems and methods of providing electronic features for creating context-aware vocabulary suggestions for an electronic device include providing a graphical user interface design area having a plurality of display elements. An electronic device user may be provided automated context-aware analysis from information from plural sources including GPS, compass, speaker identification (i.e., voice recognition), facial identification, speech content determination, user specifications, speech output monitoring, and software navigation monitoring to provide a selectable display of suggested vocabulary, previously stored words and phrases, or a keyboard as input options to create messages for text display and/or speech generation. The user may, optionally, manually specify a context. | 05-31-2012 |
Dennis Lee, King Of Prussia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080234261 | Preparation of 1,6-Disubstituted Azabenzimidazoles as Kinase Inhibitors - Novel inhibitors of Rho-kinases are disclosed. | 09-25-2008 |
| 20080275062 | Chemical Compounds - There is provided compounds of Formula (I) and salts, solvates, and physiologically functional derivatives thereof: | 11-06-2008 |
Denny L. Lee, West Chester, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110012022 | Direct Conversion X-Ray Imaging Device With Strip Electrodes - A flat panel X-ray imager using an amorphous selenium detector which uses a dielectric layer within the X-ray conversion layer to form an interface between the X-ray conversion layer and the high voltage bias electrode. To accomplish the removal of trapped counter charges at the dielectric/selenium layer, a plurality of discrete or strip electrodes are provided in contact with the dielectric layer and which are electrically coupled into distinct groups. During X-ray exposure, a high bias voltage is applied to all groups of strip electrodes. Following X-ray exposure and image readout, the groups of strip electrodes are energized using a plurality of differently-phased energization signals to drive trapped counter charges toward “gutter” strip electrodes at the sides of the detector. A second embodiment of the flat panel X-ray imager includes sandwiching the discrete electrodes in a dielectric layer applied against the selenium layer and including a continuous electrode on the opposite side of the dielectric layer. Application of a high voltage bias to the continuous electrode results in an electric field in the selenium layer that is smoothed during X-ray acquisition. Discrete electrode energization to drive trapped counter charges to the gutter electrodes occurs while the high voltage bias is present. | 01-20-2011 |
Edward B. Lee, Philadelphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100209417 | Antibody Treatment of Alzheimer's and Related Diseases - Provided is an antibody that selectively binds to an epitope formed by residues 1-11 of Aβ in an Aβ oligomer, a method comprising using the antibody to treat a disease characterized by such an Aβ amyloid deposit in a patient, and kits comprising same. | 08-19-2010 |
Eugene Lee, Malvern, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110035457 | SYSTEM AND METHOD FOR PROVIDING AN APPLICATION TO A DEVICE - The disclosed embodiments include a system and method for providing at least one electronic application to at least one device. In one embodiment, the method includes acquiring device information that relates to the device and determining whether the device supports the at least one application based on the device information. The method may further include generating an electronic message for the device wherein the message contains at least one link for acquiring the at least one application when the device supports the application. | 02-10-2011 |
Francis Y.f. Lee, Yardley, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100015149 | COMBINATION OF EPOTHILONE ANALOGS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES - Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders. | 01-21-2010 |
| 20110033457 | COMBINATION OF EPOTHILONE ANALOGS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES - Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders. | 02-10-2011 |
Garrett J. Lee, Royersford, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090241217 | Yield-improved transgenic plants - Disclosed herein are transgenic plants having a recombinant DNA construct which expresses a Hap3 transcription factor which provides enhanced resistance and/or tolerance to water deficit. More specifically the DNA constructs comprise a polynucleotide which encodes at least a functional part of a transcription factor that is a CCAAT-box DNA binding subunit or a homologous transcription factor. | 09-24-2009 |
| 20120090051 | PLANTS CONTAINING A HETEROLOGOUS FLAVOHEMOGLOBIN GENE AND METHODS OF USE THEREOF - Plant nitrogen use efficiency in corn has been improved by transformation with a flavohemoglobin gene. Plants comprising a flavohemoglobin gene have decreased nitric oxide (NO) levels, increased biomass accumulation under a sufficient nitrogen growth condition, and increased chlorophyll content under a limiting nitrogen growth condition. Additionally, these transformed plants evidence higher levels of yield. | 04-12-2012 |
George Jaw Fang Lee, Berwyn, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100187173 | METHODS OF PROVIDING AN AEROBIC MEDIUM IN A WASTEWATER TREATMENT BIOREACTOR COMPARTMENT AND RELATED SYSTEMS - The disclosure relates to methods and related systems for monitoring and controlling biological activity in municipal and industrial wastewater treatment systems. In particular, the disclosure relates to methods for controlling airflow in a bioreactor type, activated sludge wastewater treatment system by real-time monitoring of one or more parameters of the wastewater treatment system. | 07-29-2010 |
Gordon H. Lee, Newtown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090005279 | Polyalpha-Olefin Compositions and Processes to Produce the Same - This invention relates to a polyalpha-olefin (and hydrogenated analogs thereof) comprising more than 50 mole % of one or more C5 to C24 alpha-olefin monomers where the polyalpha-olefin has: a) 40 mole % or more of mm triads, b) a Bromine number of Y or greater, where Y is equal to 89.92*(V)′°5863, where V is the Kinematic Viscosity of the polyalpha-olefin measured at 100° C. in cSt, and c) 1,2 disubstituted olefins present at 7 mole % or more, preferably having Z mole % or more of units represented by the formula: where j, k and m are each, independently, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, or 22, n is an integer from 1 to 350, and where Z=8.420*Log(V)−4.048, where V is the kinematic viscosity of the polyalpha-olefin measured at 1000 C in cSt This invention also relates to process to produce such polyalpha-olefins. | 01-01-2009 |
| 20100087349 | HVI-PAO bi-modal lubricant compositions - The invention relates to oil compositions containing metallocene catalyzed high viscosity index polyalphaolefins (HVI-PAO). In one embodiment the oil formulation comprises a metallocene catalyzed HVI-PAO with a viscosity greater than 125 cSt kv 100° C. and a viscosity index greater than 100, a second base stock with a viscosity of at least 2 cSt kv 100° C. and less than 60 cSt kv 100° C. wherein the second base stock is at least 60 cSt kv 100° C. less than the metallocene HVI-PAO, an ester with a viscosity of at least 2 and less than 6, the ester comprising more than 10 weight percent and less than 30 weight percent of the oil formulation, the oil formulation having a viscosity index of greater than 195. The use of metallocene catalyzed HVI-PAOs in a bimodal blend provides advantages in improved shear stability, and other properties related to shear stability. | 04-08-2010 |
| 20100105589 | Chromium HVI-PAO bi-modal lubricant compositions - The invention relates to oil compositions containing chromium catalyzed high viscosity index polyalphaolefins (HVI-PAO). In one embodiment the oil formulation comprises a chromium catalyzed HVI-PAO with a viscosity greater than 125 cSt kv 100° C. and a viscosity index greater than 100, a second base stock with a viscosity of at least 2 cSt kv 100° C. and less than 60 cSt kv 100° C. wherein the second base stock is at least 120 cSt kv 100° C. less than the chromium HVI-PAO, an ester with a viscosity of at least 2 and less than 6, the ester chosen from the group consisting of monoester, di-octyl sebacate and any combination thereof comprising more than 10 weight percent and less than 30 weight percent of the oil formulation, the oil formulation having a viscosity index of greater than 180. | 04-29-2010 |
Haksu Lee, Ambler, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100222459 | Polymer modified carbohydrate curable binder composition - A curable aqueous binder composition comprising one or more amine reactant selected from the group consisting of: a protein, a peptide, an amino acid, an ammonium salt of a polycarboxylic acid, an ammonium salt of a (poly)hydroxy-(poly)carboxylic acid; one or more carbohydrate; and one or more emulsion polymer; and the use thereof as thermosetting binders. Also described are composite materials comprising the curable binder composition, and methods of application. | 09-02-2010 |
| 20110262648 | DURABLE THERMOSETS FROM REDUCING SUGARS AND PRIMARY POLYAMINES - The present invention provides thermosetting aqueous binder compositions of one or more diprimary diamine, e.g. lysine, or poly(primary amine), e.g. polyethylenimine, and one or more reducing sugar in which the number of equivalents of primary amine relative to the number of equivalents of carbonyl groups in the reducing sugar ranges from 0.4:1 to 2:1, the binders being suitable for use on fiber, nonwoven, woven web and finely divided substrates. The binders are at least substantially formaldehyde free, need no polycarboxylic or polycarboxylate component, and yet provide excellent hot wet tensile strength when cured for as little time as a minute or less in use. | 10-27-2011 |
Hoi Kwan Lee, State College, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110085279 | SELF HEALING HIGH ENERGY GLASS CAPACITORS - A self healing high energy glass capacitor is provided. The capacitor can have a glass layer with a top surface and a bottom surface. A top sacrificial layer can extend across the top surface and a bottom sacrificial layer can extend across the bottom surface. In addition, a top electrode can extend across the top sacrificial layer and a bottom electrode can extend across the bottom sacrificial layer. In some instances the glass capacitor has an energy breakdown of at least 6 joules per cubic centimeter. | 04-14-2011 |
Hotaik Lee, State College, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100217162 | METHODS OF USING HIGH INTENSITY FOCUSED ULTRASOUND TO FORM AN ABLATED TISSUE AREA CONTAINING A PLURALITY OF LESIONS - A device and method for ablating tissue is disclosed comprising the steps of acquiring an anatomical image of a patient, correlating the image to the patient, guiding an ablating member within the patient while tracking the position of the ablating member in the patient, positioning the ablating member in a desired position to ablate tissue, emitting ablating energy from the ablating member to form an ablated tissue area and removing the ablating member from the patient. | 08-26-2010 |
Hyeong Jae Lee, State College, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100133461 | NBT based lead-free piezoelectric materials for high power applications - Piezoelectric compounds of the formula xNa | 06-03-2010 |
Jeannie T. Lee, Weston, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090215872 | Methods for Controlling Stem Cell Differentiation - Disclosed herein are methods for controlling stem cell differentiation through the introduction of transgenes having Xic, Tsix, or Xite sequences to block differentiation and the removal of the transgenes to allow differentiation. Also disclosed are small RNA molecules and methods for using the small RNA molecules to control stem cell differentiation. Also disclosed are stem cells genetically modified by the introduction of Xic, Tsix, or Xite sequences. | 08-27-2009 |
| 20100203632 | METHODS FOR CONTROLLING STEM CELL DIFFERENTIATION - Disclosed herein are methods for controlling stem cell differentiation through the introduction of transgenes having Xic, Tsix, Xite, or Xic flanking region sequences to block differentiation and the removal of the transgenes to allow differentiation. Also disclosed are small RNA molecules and methods for using the small RNA molecules to control stem cell differentiation. Also disclosed are stem cells genetically modified by the introduction of Xic, Tsix, XUe, or Xic flanking region sequences. | 08-12-2010 |
| 20110008784 | METHODS AND COMPOSITIONS FOR IDENTIFYING UNDIFFERENTIATED STEM CELLS AND ASSESSING CELL HEALTH - Disclosed herein are methods and compositions for the identification of teloRNA marks to assess the differentiation status of an individual stem cell or a population of stem cells, to diagnose whether and to what extent a stem cell or stem cell culture has already initiated cell differentiation, and to monitor the differentiation status of an individual stem cell or a stem cell culture during passage. The use of these methods and compositions to monitor the pluripotency and differentiation status of a stem cell or stem cell culture during differentiation enables the identification of undifferentiated and pluripotent stem cells prior to the initiation of differentiation. The methods and compositions can also be used to assess and maintain cell viability; to identify cells or a population of cells that are in a state of poor cell health; and to reduce cell growth or treat a diseased cell including, for example, pre-cancerous cells, cancerous cells, apoptotic cells, aging cells, cells undergoing stress, and otherwise diseased or dysfunctional cells. | 01-13-2011 |
Jennifer Henrica Lee, Berwyn, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090162375 | RESISTIN ANTAGONISTS AND THEIR USE - Resistin antagonists, including antibodies reactive with defined epitopes, are disclosed. Antigens useful for raising antibodies against human resistin are also disclosed. Methods of utilizing resistin antagonists to treat or alleviate the symptoms of the diseases with aberrant fibroblast activity including interstitial lung diseases, hypertrophic scarring, keloid scarring and scleroderma are also disclosed. Methods of utilizing resistin as a biomarker to diagnose the risk and/or progression of osteoarthritis are also disclosed. Further disclosed are methods of utilizing the antagonists to treat or alleviate the symptoms of osteoarthritis. | 06-25-2009 |
| 20110071277 | RESISTIN ANTAGONISTS AND THEIR USE - Resistin antagonists, including antibodies reactive with defined epitopes, are disclosed. Antigens useful for raising antibodies against human resistin are also disclosed. Methods of utilizing resistin antagonists to treat or alleviate the symptoms of the diseases with aberrant fibroblast activity including interstitial lung diseases, hypertrophic scarring, keloid scarring and scleroderma are also disclosed. Methods of utilizing resistin as a biomarker to diagnose the risk and/or progression of osteoarthritis are also disclosed. Further disclosed are methods of utilizing the antagonists to treat or alleviate the symptoms of osteoarthritis. | 03-24-2011 |
Jerald D. Lee, Mendenhall, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080212090 | FLUOROMETER WITH LOW HEAT-GENERATING LIGHT SOURCE - This invention concerns a fluorometer preferably combined with a thermal cycler useful in biochemical protocols such as polymerase chain reaction (PCR) and DNA melting curve analysis. The present fluorometer features a low heat-generating light source such as a light emitting diode (LED), having a one-to-one correspondence to each of a plurality of sample containers, such as capped PCR tubes in a standard titer tray. The fluorometer of the present invention further comprises an optical path between each LED and its correspondingly positioned container, and another optical path between each fluorescing sample within the positioned container and an optical signal sensing means. The instrument can be computer controlled. | 09-04-2008 |
| 20090230323 | Fluorometer with low heat-generating light source - This invention concerns a fluorometer preferably combined with a thermal cycler useful in biochemical protocols such as polymerase chain reaction (PCR) and DNA melting curve analysis. The present fluorometer features a low heat-generating light source such as a light emitting diode (LED), having a one-to-one correspondence to each of a plurality of sample containers, such as capped PCR tubes in a standard titer tray. The fluorometer of the present invention further comprises an optical path between each LED and its correspondingly positioned container, and another optical path between each fluorescing sample within the positioned container and an optical signal sensing means. The instrument can be computer controlled. | 09-17-2009 |
| 20110207142 | FLUOROMETER WITH LOW HEAT-GENERATING LIGHT SOURCE - This invention concerns a fluorometer preferably combined with a thermal cycler useful in biochemical protocols such as polymerase chain reaction (PCR) and DNA melting curve analysis. The present fluorometer features a low heat-generating light source such as a light emitting diode (LED), having a one-to-one correspondence to each of a plurality of sample containers, such as capped PCR tubes in a standard titer tray. The fluorometer of the present invention further comprises an optical path between each LED and its correspondingly positioned container, and another optical path between each fluorescing sample within the positioned container and an optical signal sensing means. The instrument can be computer controlled. | 08-25-2011 |
Jinwoo Lee, Souderton, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090041467 | Field-Configurable Optical Network Terminal Device - Described herein are systems and methods for a field-configurable optical network terminal (ONT) device at a subscriber to provide one or more communication services to the subscriber. The field-configurable ONT device is of a modular design operable for the insertion of additional communication modules or removal of existing communication modules from the ONT device for scaling the device to increased or decreased communication capacity as desired. | 02-12-2009 |
Jong-Chang Lee, Macungie, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100122228 | METHOD AND SYSTEM FOR CONDUCTING DESIGN EXPLORATIONS OF AN INTEGRATED CIRCUIT - Method and system for conducting design explorations of an integrated circuit are disclosed. In one embodiment, the method includes obtaining a design description of the integrated circuit that includes a virtual design block, creating a representative netlist for representing the virtual design block, where the representative netlist includes one or more soft design models, and each soft design model comprises one or more template cells for modeling a portion of the integrated circuit. The method further includes defining physical attributes for the one or more soft design models in accordance with area requirements of the virtual design block, where the one or more soft design models are described with flexible shape and pin locations, performing design explorations of the integrated circuit using the one or more soft design models and their corresponding template cells, and generating a representative implementation of the integrated circuit using results of the design explorations. | 05-13-2010 |
Joon S. Lee, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110208113 | Directed Cell-Based Therapy Using Microbubble Tagged Cells - The disclosed technology describes compositions and methods useful for providing cell based therapy. For example, one embodiment of cell based therapy involves the regeneration of injured tissue and/or promoting wound healing. Certain embodiments provide improved therapeutic compositions using microbubbles by delivering biological progenitor cells to the injured tissues. The administration of the microbubbles is directed by acoustic radiation forces that interact with embodiments of microbubbles comprising an acoustically active gas. As such, a high efficiency of progenitor cell delivery to injured tissue is realized. One advantage of this technique over targeted delivery of pharmaceutical compounds, is that the delivered progenitors cells may be derived from the patient (i.e., personalized therapy), thereby avoiding side effects, allergic reactions, and overall problems associated with refractive drug responses. | 08-25-2011 |
Joseph Lee, Warrington, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090130287 | Microcrystalline Cellulose Compositions - Ultra-fine microcrystalline cellulose compositions are disclosed which comprise co-attrited microcrystalline cellulose and a hydrocolloid. The compositions have a mean particle size of less than 10 microns. The compositions are prepared by subjecting a high solids mixture of microcrystalline cellulose and a hydrocolloid to high shear forces in the presence of an anti slip agent preferably an aqueous solution of an inorganic salt. The compositions are especially useful in food, pharmaceutical and cosmetic and industrial applications. | 05-21-2009 |
| 20110135798 | Microcrystalline Cellulose Compositions - Ultra-fine microcrystalline cellulose compositions are disclosed which comprise co-attrited microcrystalline cellulose and a hydrocolloid. The compositions have a mean particle size of less than 10 microns. The compositions are prepared by subjecting a high solids mixture of microcrystalline cellulose and a hydrocolloid to high shear forces in the presence of an anti slip agent preferably an aqueous solution of an inorganic salt. The compositions are especially useful in food, pharmaceutical and cosmetic and industrial applications. | 06-09-2011 |
Judithann Lee, King Of Prussia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090088374 | NOVEL USE - The present invention relates generally to the use of PA126 polypeptides and polynucleotides for healing various wounds arising from different causes. | 04-02-2009 |
| 20090137465 | NOVEL USE - The present invention relates generally to the use of PA131 polypeptides and polynucleotides for healing various wounds arising from different causes. | 05-28-2009 |
Ju-Il Lee, Sewickley, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100157485 | WAVELETS-BASED DETECTION OF PROXIMITY BETWEEN A SENSOR AND AN OBJECT - A circuit includes a proximity detection component that applies wavelet analysis to a sensed signal from a sensor and responsively provides an output indicative of whether proximity exists between the sensor and an object that causes the sensor to produce the sensed signal. | 06-24-2010 |
Kang W. Lee, Allentown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080258757 | INTEGRATED CIRCUIT FEATURE DEFINITION USING ONE-TIME-PROGRAMMABLE (OTP) MEMORY - In one embodiment, a integrated circuit (IC) configurable to have any one of a plurality of different feature sets, the IC including (a) one or more feature blocks adapted to be independently enabled or disabled, (b) a one-time-programmable (OTP) memory cell for each feature block, the OTP memory cell storing a value, and (c) a feature control module for each feature block, each feature control module connected between the corresponding OTP memory cell and the corresponding feature block, and adapted to enable or disable the corresponding feature block based on the value stored in the corresponding OTP memory cell. The OTP memory cells are programmed by a vendor to select the particular feature set for the IC which is to be available to a purchaser. | 10-23-2008 |
| 20090146687 | INTEGRATED CIRCUIT FEATURE DEFINITION USING ONE-TIME-PROGRAMMABLE (OTP) MEMORY - In one embodiment, a integrated circuit (IC) configurable to have any one of a plurality of different feature sets, the IC including (a) one or more feature blocks adapted to be independently enabled or disabled, (b) a one-time-programmable (OTP) memory cell for each feature block, the OTP memory cell storing a value, and (c) a feature control module for each feature block, each feature control module connected between the corresponding OTP memory cell and the corresponding feature block, and adapted to enable or disable the corresponding feature block based on the value stored in the corresponding OTP memory cell. The OTP memory cells are programmed by a vendor to select the particular feature set for the IC which is to be available to a purchaser. | 06-11-2009 |
| 20090164831 | Controlled Default OTP Settings for ASICs - An OTP and Reset Assert Counter and a method for protecting one-time programmable memory settings during read-out from an OTP memory block. The OTP memory block is set at ground and in a reset mode with a clock driven External Reset (RSTB) signal set at ground true active. A Delay Counter is programmed with a time delay to correspond with the time that is inherently needed by the OTP Memory block to complete a read-out process that begins with the External Reset (RSTB) signal being set to HIGH; and an input Clock signal is delayed by the Delay Counter for a duration of the time delay that begins with the External Reset (RSTB) signal being set to HIGH. | 06-25-2009 |
Kung H. Lee, Chadds Ford, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110212836 | Environment favorable for plant(vegetation) growth, insect control and effective use of fertilizers - This invention relates to a plant (vegetation) protecting and regulating environment which uses excessive amounts of carbon dioxide (CO2) coupled with reduced amounts of oxygen (O2) to, simultaneously and collectively, (1) promote plant (vegetation) growth, (2) provide insect control and (3) render effective use of fertilizers. As an illustrative example, such said environment can be provided by using the waste flue gases from coal-fired power plants. | 09-01-2011 |
Ling Lee, Lansdale, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090012061 | A Method of Treating Cancer - The present invention relates to a method of treating cellular proliferative diseases, in particular cancer, which comprises administering a modulator of the activity of the mitotic kinesin KSP, wherein the activity of the KSP modulator is dependent on the presence of microtubules. It is believed that the KSP modulators utilized in the instant method bind to the KSP protein in a previously unreported manner, since the compounds do not bind competitively with respect to either microtubules or ATP, the substrates of KSP. The modulators useful in the instant methods are furthermore not active against the non-microtubule stimulated activity of KSP. Cellular proliferative diseases that may be treated using the method disclosed herein are, for example cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. | 01-08-2009 |
Mark H. Lee, Philadelphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100285086 | Biomimetic Extracellular Matrices - The present invention is directed to hydrogel compositions for biotechnology applications. Specifically, the invention provides hydrogels mimicking the ECM and uses thereof. | 11-11-2010 |
Ping I. Lee, Radnor, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090074869 | PHARMACEUTICAL FORMULATIONS - Disclosed are pharmaceutically acceptable PDE V inhibitor Formulations that are especially useful for treating male erectile and female sexual dysfunction and other physiological disorders. | 03-19-2009 |
Regina Concepta Lee, Souderton, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110198356 | Paints to go a.k.a paint stay - A palette in which one can store paint in individual paint pots directly on the palette. Each paint pot has an air tight lid that keeps the paint safely secure when not in use. The air tight lid seals the paint and keeps it from drying out for an extended period of time. This also makes the palette easy to stow and carry knowing the paint will not spill when the lid is securely sealed in place. This also allows for easy clean up of excess paint when finished using the palette. | 08-18-2011 |
Robert W. Lee, Boyerstown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110165251 | LIQUID DOSAGE COMPOSITIONS OF STABLE NANOPARTICULATE ACTIVE AGENTS - The present invention relates to liquid dosage compositions of stable nanoparticulate active agents. The liquid dosage compositions of the invention include osmotically active crystal growth inhibitors that stabilize the nanoparticulate active agents against crystal and particle size growth of the active agent. | 07-07-2011 |
Robert W. Lee, Boyertown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100226932 | Adjuvant and Vaccine Compositions - Abstract Compositions comprising an emulsion and aluminum salt nano-/micro-particles surface stabilized with at least one surfactant are useful as immunological adjuvants. The emulsion of these compositions comprises at least one oil; at least one surfactant; a plurality of surfactant vesicles; optionally at least one sterol; and an aqueous phase. The present invention also provides vaccines comprising one or more antigens combined with the emulsion and surface stabilized aluminum salt particles of the present invention, or one or more antigens combined with non-ionic surfactant vesicles. | 09-09-2010 |
| 20110311457 | METHODS FOR IMAGING VASCULAR INFLAMMATION USING IMPROVED NANOPARTICLE CONTRAST AGENTS - The present invention also provides methods and compositions for imaging and evaluating, e.g., blood flow or inflammation in a subject. Such evaluations are important in a number of clinical diagnoses, including assessing organ damage associated with angina pectoris, heart attack, stroke, cancer, atherosclerosis, and the like, as well as assessing vessel leakages associated with aneurisms, diffuse bleedings after trauma, and the like. | 12-22-2011 |
Ruey-Min Lee, Ambler, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120087913 | INDUCTION OF TUMOR HYPOXIA FOR CANCER THERAPY - Methods and compositions for enhancing the ability of hypoxia-activated bioreductive agents to kill tumor cells within solid tumors are provided. Local regions of hypoxia are created within a tumor, or within a region containing a tumor, resulting in enhanced activation of hypoxia-activated bioreductive agents (e.g. tirapazamine) within the local region. The activated hypoxia-activated bioreductive agents kill tumor cells in the hypoxic region by catalyzing DNA stand breakage within the tumor cells. Because the activity is localized, side effects that typically occur as a result of systemic administration of bioreductive agents are reduced. | 04-12-2012 |
Sang Boem Lee, Pittsburgh, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080286319 | Antimicrobial surfaces and methods for preparing antimicrobial surfaces - The present invention relates to biocidal articles. In an embodiment the biocidal article comprises a plurality of polymers having biocidally active groups. The polymers are attached to a surface and may have a polydispersity less than 3. The biocidally active groups may comprise at least one of a quaternary ammonium salt, a quaternary phosphonium salt or a chloroamine. The attached polymers may be any microstructure, topology or composition, such as, a homopolymer, block copolymer, multiblock copolymer, a random copolymer, graft polymer, a branched or a hyperbranched polymer, and a gradient copolymer. The present invention also comprises a process for the preparation of a biocidal article. Embodiments of the process comprise polymerizing radically polymerizable monomers from an initiator attached to a surface, wherein at least a portion of the monomers comprise a group capable of being converted to a biocidally active group, and converting the group to the biocidally active group. | 11-20-2008 |
Sang B. Lee, Harrison City, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100137541 | End-to-end joining of nanotubes - A method for joining nanotubes end-to-end, includes contacting the nanotubes with a joining fluid. The joining fluid has at least one property that is different from at least one property associated with ends of the nanotubes. In one embodiment, the method further includes contacting the nanotubes with a first, treating fluid and removing the bulk first fluid before the nanotubes are contacted with the joining fluid. The joining fluid is immiscible in the treating fluid to effect end-to-end joining of the nanotubes. | 06-03-2010 |
Sang Beom Lee, Harrison City, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080293842 | Self Assembled Nanotubes and Methods for Preparation Thereof - The invention concerns the synthesis of nanotubes and nanocarpets by the spontaneous self-assembly of single chain achiral diacetylenes The monomer units may be cross-linked by UV irradiation to form stable supramolecular assemblies. The nanotubes of the invention, which are remarkably homogeneous in length and diameter, exhibit chromogenic and antibacterial properties. | 11-27-2008 |
| 20090022974 | TREATED ARTICLES AND METHODS OF TREATING ARTICLES - Treated articles are provided. The treated articles may have at least one functional particle in a substrate and at least one blocking material. The blocking material inhibits the release of the at least one functional particle from the substrate. Methods of treating articles are further provided. | 01-22-2009 |
Sang Kook Lee, Breinigsville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100294133 | Pressure Swing Adsorption Method and System With Multiple-Vessel Beds - Pressure swing adsorption process for the separation of a feed gas mixture comprising (a) providing a pressure swing adsorption system comprising one or more composite beds, each composite bed comprising adsorbent material disposed in two or more vessels in parallel flow configuration, each vessel having a feed end and a product end; (b) performing cyclic sequential steps comprising adsorption/make product, withdrawing gas at decreasing pressure from the composite bed, purging the composite bed, and introducing gas into the composite bed at increasing pressure; and (c) for any of the sequential steps, setting a flow rate or flow rates of one or more gases selected from the group consisting of gas introduced into or withdrawn from the feed end or ends of any of the two or more vessels and gas introduced into or withdrawn from the product end or ends of any of the two or more vessels. | 11-25-2010 |
Seunghun Paul Lee, Newton, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100248987 | Screening Assay for Inhibitors of TRPA1 Activation by a Lower Alkyl Phenol - The invention relates an assay useful for screening and identifying compounds as modulators of lower alkyl phenol activation of TRPA1. Thymol, a lower alkyl phenol anti-infective and the active ingredient in, e.g., mouthwashes, is stringent and has an objectionable burning taste sensation. Thymol activates the transient receptor potential like ion channel TRPA1. The assay described and claimed herein involves measurement of activation of TRPA1 and enables the screening of compounds that inhibit lower alkyl phenol, or thymol activation of TRPA1. Inhibitors of thymol activation of TRPA1 can be used to prevent the objectionable taste of thymol in medical uses where taste limits acceptance. | 09-30-2010 |
Soonil Lee, State College, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120090657 | REDUCED LOW SYMMETRY FERROELECTRIC THERMOELECTRIC SYSTEMS, METHODS AND MATERIALS - n-type and p-type thermoelectric materials having high figures of merit are herein disclosed. The n-type and p-type thermoelectric materials are used to generate and harvest energy in thermoelectric power generator and storage modules comprising at least one n-type thermoelectric element coupled to at least one p-type thermoelectric element. | 04-19-2012 |
S. Paul Lee, Newtown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080306030 | Use of a TRPM5 Inhibitor to Regulate Insulin and GLP-1 Release - The present invention is directed to methods of enhancing insulin release, GLP-1 release, and insulin sensitivity, methods of increasing insulin gene expression, methods of decreasing gastric secretion and emptying and glucagons secretion, and methods of inhibiting food intake, and methods of treating diabetes mellitus, insulin resistance syndrome, hyperglycemia, and obesity comprising administering to a subject an effective amount of a TRPM5 inhibitor. | 12-11-2008 |
| 20090175848 | Modulation of the Cooperativity Between the Ion Channels TRPM5 and TRPA1 - The present invention is related to modulating TRPA1 ion channel activity by targeting the ion channel TRPM5. The cooperativity between the ion channels can be used to modulate pain, mechanosensation and taste responses triggered through TRPA1 by modulating the activity of TRPM5 | 07-09-2009 |
S. Paul Lee, Yardley, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090136975 | Non-desensitizing mutant of the transient receptor potential TRPM5 ion channel - There exists a need in the art for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels, such as TRPM5. Current methods, especially electrophysiological, suffer from a lack of sensitivity, rapid signal loss, low throughput, and are labor intensive. The claimed methods and compositions provide electrophysiology methods that allow prolonged sample testing and fluorescent assays with an optical readout that gives rapid readout of the results, has a high signal to noise background ratio, are easy to use, can be modified for automation and miniaturization, and provide verification that a compound specifically modulates TRPM5. | 05-28-2009 |
| 20100248988 | High Throughput Screening Assay for the TRPM5 Ion Channel - There exists a need in the art for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels, such as TRPM5. Current methods suffer from a lack of sensitivity, low throughput, and are labor intensive. The claimed methods provide fluorescent assays with an optical readout that gives rapid readout of the results, has a high signal to noise background ratio, are easy to use, can be modified for automation and miniaturization, and provide verification that a compound specifically modulates TRPM5. | 09-30-2010 |
Taejin Lee, State College, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090134975 | TAG ESTIMATION METHOD AND TAG IDENTIFICATION METHOD FOR RFID SYSTEM - Provided are a tag estimation method and a tag identification method using the same in a RFID system. In the tag estimating method, a reader divides tags in an identifiable area into a predetermined number of groups. Tags are identified by applying a pilot frame L | 05-28-2009 |
Taekyu Lee, Doylestown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100048612 | BICYCLIC HETEROCYCLES AS CANNABINOID-1 RECEPTOR MODULATORS - The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formula: | 02-25-2010 |
Tong C. Lee, Murrysville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110236721 | STEEL COMPOSITIONS, METHODS OF FORMING THE SAME, AND ARTICLES FORMED THEREFROM - Maraging steel compositions, methods of forming the same, and articles formed therefrom comprising, by weight, 15.0 to 20.0% Ni, 2.0 to 6.0% Mo, 3.0 to 8.0% Ti, up to 0.5% Al, the balance Fe and residual impurities. The composition may be a first layer of a composite plate, and may have a second layer deposited on the first layer, the second layer having a composition comprising, by weight, 15.0 to 20.0% Ni, 2.0 to 6.0% Mo, 1.0 to 3.0 Ti, up to 0.5% Al, the balance Fe and residual impurities. The first layer may have a hardness value ranging from 58 to 64 RC, and the second layer may have a hardness value ranging from 48 to 54 RC. The first layer may be formed employing powdered metallurgical techniques. Articles formed from the compositions include armored plate. | 09-29-2011 |
Virginia M.y. Lee, Philadelphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090263824 | Detection of Neurodegenerative Disease - Provided are methods of assessing the absence or presence of a neurodegenerative disease in a subject comprising characterizing TDP-43 in a tissue sample of the subject. Also disclosed are methods for diagnosing a neurodegenerative disease in a subject, and methods for determining the efficacy of a drug against a neurodegenerative disease. Novel antibodies that bind to TDP-43 are also provided. | 10-22-2009 |
| 20100209417 | Antibody Treatment of Alzheimer's and Related Diseases - Provided is an antibody that selectively binds to an epitope formed by residues 1-11 of Aβ in an Aβ oligomer, a method comprising using the antibody to treat a disease characterized by such an Aβ amyloid deposit in a patient, and kits comprising same. | 08-19-2010 |
Virginia M-Y. Lee, Philadelphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100068308 | Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease - Provided is a novel use of therapeutic concentrations of an inhibitor of glycogen synthase kinase-3 (GSK-3), including lithium or any other GSK-3 inhibitor, to block, reduce or inhibit processing of amyloid precursor proteins to beta-amyloid (Aβ) peptides, which are now believed to be the principal cause of Alzheimer's disease, thereby providing methods useful for the prevention, inhibition or reversal of the disease. Also provided are methods of using agents that specifically target the α isoform of GSK-3, which is responsible for APP processing, making such selective GSK-3α-specific inhibitors especially useful in the treatment, prevention, and possible reversal of Alzheimer's disease. Further provided are kits and screening methods associated with the present methods. | 03-18-2010 |
Younghee Lee, Blue Bell, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080280891 | Anti-cancer agents and uses thereof - The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: | 11-13-2008 |
| 20090093479 | ANTI-CANCER AGENTS AND USES THEREOF - The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: | 04-09-2009 |
| 20090235442 | Ventilated Toilet Apparatus and Dual Function Toilet Seat - A ventilated toilet apparatus includes a toilet seat assembly ( | 09-24-2009 |
Yu-Hua Lee, Malvern, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110288116 | IAP INHIBITORS - The present invention describes compounds of the following formula: processes for their preparation, pharmaceutical compositions containing them, and their use in therapy. The compounds of the present invention inhibit IAPs (inhibitors of apoptosis proteins) and thus are useful in the treatment of cancer, autoimmune diseases and other disorders where a defect in apoptosis is implicated. | 11-24-2011 |
Yu-Kai Lee, Exton, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110190344 | BENZIMIDAZOLE MODULATORS OF VR1 - The invention is directed to compounds of Formula (I): | 08-04-2011 |
| 20110190364 | BENZIMIDAZOLE MODULATORS OF VR1 - The invention is directed to compounds of Formula (I): | 08-04-2011 |
Yun Han Lee, Mountville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100215556 | NANOPORE REACTIVE ADSORBENTS FOR THE HIGH-EFFICIENCY REMOVAL OF WASTE SPECIES - A nanopore reactive adsorbent composite material, which may be a porous adsorbent comprising a chemically surface face modified gel, has a composition and micro structure, which integrals ion exchange components such as hydroxy apatite. | 08-26-2010 |